(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.35%) $91.45
4 days till quarter result
(bmo 2024-05-09)
Expected move: +/- 7.74%
21.04% $ 10.16
Live Chart Being Loaded With Signals
Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy, and other disorders of the peripheral and central nervous systems...
Stats | |
---|---|
Volumen de hoy | 1.47M |
Volumen promedio | 824 787 |
Capitalización de mercado | 281.54M |
EPS | $0 ( 2024-04-01 ) |
Próxima fecha de ganancias | ( $0 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -7.81 |
ATR14 | $0.0830 (0.82%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-05 | Morisset Valerie | Buy | 17 847 | Common Stock |
2024-04-05 | Morisset Valerie | Sell | 17 847 | Stock Option (Right to Buy) |
2024-03-18 | Pimblett Emily | Buy | 40 000 | Restricted Stock Units |
2023-09-20 | Morisset Valerie | Buy | 15 297 | Common Stock |
2023-09-20 | Morisset Valerie | Buy | 5 431 | Common Stock |
INSIDER POWER |
---|
39.66 |
Last 75 transactions |
Buy: 17 601 902 | Sell: 12 020 423 |
Volumen Correlación
Eliem Therapeutics, Inc. Correlación
10 Correlaciones Más Positivas | |
---|---|
BNIXU | 0.883 |
DFPH | 0.864 |
THCP | 0.849 |
VOSOU | 0.842 |
ANZUU | 0.84 |
CSTE | 0.835 |
HCCC | 0.831 |
LWAC | 0.822 |
NISN | 0.821 |
TMTS | 0.82 |
10 Correlaciones Más Negativas | |
---|---|
GIAC | -0.875 |
GOODM | -0.847 |
CTAC | -0.817 |
CMLT | -0.815 |
PRSR | -0.814 |
VAXX | -0.808 |
RMRM | -0.801 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Eliem Therapeutics, Inc. Correlación - Moneda/Commodity
Eliem Therapeutics, Inc. Finanzas
Annual | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $0 (0.00 %) |
EPS: | $-1.300 |
FY | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $0 (0.00 %) |
EPS: | $-1.300 |
FY | 2022 |
Ingresos: | $0 |
Beneficio Bruto: | $0 (0.00 %) |
EPS: | $-1.720 |
FY | 2021 |
Ingresos: | $0.00 |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-3.05 |
Financial Reports:
No articles found.
Eliem Therapeutics, Inc.
Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy, and other disorders of the peripheral and central nervous systems. Its two lead drug candidates are ETX-810 for chronic pain, which is in Phase IIa clinical trial; and ETX-155 for the treatment of major depressive disorder, perimenopausal depression, and focal onset seizures that is in Phase I clinical trial. The company also develops preclinical pipeline programs, such as Kv7 Program for pain, epilepsy, and depression; and Anxiolytic for the treatment of generalized anxiety disorder. Eliem Therapeutics, Inc. was incorporated in 2018 and is headquartered in Redmond, Washington.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico